Intra Cellular Therapies



Ebitda Zmiana Data
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
ALKERMES USD 121.55M 4.99M 2025-09
Biogen USD 573.2M 253.7M 2025-12
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Cytokinetics USD -107.82M 45.51M 2025-06
Esperion Therapeutics USD -27.51M 9.5M 2023-09
Gilead Sciences USD 4.03B 628M 2025-09
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
J&J USD 9.52B 389M 2025-09
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Nektar Therapeutics USD -31.81M 70K 2023-09
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Novartis USD 5.84B 235M 2025-09
Prothena USD -39.53M 12.25M 2025-09
RedHill Biopharma USD 2.69M 108.46M 2023-06
Supernus Pharmaceuticals USD 41.9M 432K 2025-09
United Therapeutics USD 436.8M 34.2M 2025-06
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12


Intra Cellular Therapies - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.